Long-term effects of tocilizumab on retinal and choroidal inflammation in Birdshot uveitis
TCZ is effective in reducing retinal vasculitis and CRT in refractory Birdshot uveitis over time, but might be less effective in managing choroidal inflammation. Further studies are needed to determine the optimal treatment strategies for TCZ therapy in NIU.
Authors
- Anne Rübsam (ORCID: https://orcid.org/0000-0001-6202-1710)
- Lynn S. zur Bonsen (ORCID: https://orcid.org/0000-0002-0165-6744)
- Daniel Schulze (ORCID: https://orcid.org/0000-0001-9415-2555)
- Uwe Pleyer (ORCID: https://orcid.org/0000-0002-5569-1473)
- Dominika Pohlmann (ORCID: https://orcid.org/0000-0002-9866-0431)
- Steffen E. Künzel (ORCID: https://orcid.org/0000-0002-6466-168X)
Institutions
- Humboldt-Universität zu Berlin (DE)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- Journal of Ophthalmic Inflammation and Infection
- Published
- 2024-11-21
- DOI
- https://doi.org/10.1186/s12348-024-00443-9
- Citations
- 4
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 2.15
Funders
- Deutsche Forschungsgemeinschaft
- Charité – Universitätsmedizin Berlin
- Berlin Institute of Health